Navigation Links
Stryker Operating Results for Quarter Ended March 31, 2009
Date:4/20/2009

nternational) and enter the passcode 86263096.

Forward-Looking Statements

Certain statements made during the call may constitute forward-looking statements. They will be based upon management's current expectations and will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: further weakening of economic conditions that could adversely affect the level of demand for the Company's products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company's products; changes in foreign exchange markets; regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; unfavorable resolution of income tax audits; changes in financial markets; and changes in the competitive environment. Additional information concerning these and other factors is contained in the Company's filings with the U.S. Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital
'/>"/>

SOURCE Stryker Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting
2. Stryker to Host Conference Call on April 20, 2009
3. Stryker to Host Analyst Meeting
4. Stryker Operating Results for Quarter Ended December 31, 2008
5. LegalView Developing Cranial Implant Information Portal Detailing the Recall of Stryker Cranial Implant Kits
6. Stryker Updates Expected 2008 Results and Provides 2009 Outlook
7. Stryker To Present at Investor Conference
8. Stryker Increases Annual Dividend by Over 20%
9. Stryker Announces Organizational and Leadership Changes
10. Stryker to Present at Investor Conferences
11. Stryker To Present at Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire/-SentinelleMedicalInc.,aleadingmanufactur...ndCalgaryScientificInc.,aleadingproviderofsoftware...gis(TM)Breast4DAdvancedVisualizationsoftware. ,...rintWebclientbasedmedicalimagingofferinginthemarke...ero-footprintaccess-requiringnosoftwaredownload,an...
(Date:11/25/2009)...e-USNewswire/--TheBlackAIDSInstituterecentlyheldBo...ipfor2010. ,, ThenewBoardMembersareahighlydiver...finance,governmenthealthprograms,editorial,andbusi...geofpersonalbackgroundsincludingbothheterosexualan...ndrepresentingmultipleagegroups. ,, (Photo: htt...
(Date:11/25/2009)...f a statistically significant survival benefit fro... receptor (ER)-positive tumors had high levels of ...ha S118-P), according to a brief communication pub...ational Cancer Institute . , Approximately 50% o...eclinical studies have shown that ER-alpha S118-P ...
(Date:11/25/2009)...eumatoid arthritis, could help newly diagnosed dia...25 (HealthDay News) -- A drug commonly used to tre... now also shows some promise in helping patients n..., rituximab (Rituxan), helped patients keep produc...ease had destroyed some of their pancreatic beta c...
(Date:11/25/2009)... signs of trouble with the H1N1 vaccine, , ...ngoing H1N1 swine flu pandemic may be driving a re...atients, a U.S. health official said Wednesday. ,...cal infections around the country," Dr. Anne Schuc...ion and Respiratory Diseases at the U.S. Centers f...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
... Dec. 17 Erica Frank, a medical doctor and,resear...eves people anywhere in,the world working to remed...e,best medical information - not just those who ha... Frank,s idea led her to develop Health Sciences O...
...oosts survival, even when tumor is linked to hepat... 16 (HealthDay News) -- The drug sorafenib increas... advanced liver cancer, according to the results o...(Nexavar) twice a day in six-week cycles, while th...
... Dec. 17 The LCA-Vision Full Value Committee,comp...d Alan H. Buckey, today,announced that it has sent...NasdaqGS: LCAV). The members of The LCA-Vision Ful... from the LCA-Vision Full Value Committee, ATTE...
...ntments continue to strengthen diagnostics product... Dec. 17 HistoRx, Inc., announced today that it h...d position of Vice President, Diagnostics Marketin...e diagnostics and pharmaceuticals industries. Befo...
... GlaxoSmithKline (LSE:GSK) (NYSE:GS...AX) today announced a worldwide strategic alliance...bitors of endosomal Toll-like Receptors (TLRs) for... LONDON & PHILADELPHIA & BE...
... Independent Living Aids (ila) is p...ucts in the blindness and visual impairment field....ve Voice Responsive Clock, is a natural addition t... Aids (ila) is proud to be the exclusive distribut...
Other Medicine News:Health News:Vivisimo Search Delivers Medical Knowledge to Global Health-Care Community 2Health News:Drug Helps Asians Battling Liver Cancer 2Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 2Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 3Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 4Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 5Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 6Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 7Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 8Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 9Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 10Health News:LCA-Vision's Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders 11Health News:HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor 2Health News:HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor 3Health News: GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases – 2Health News: GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases – 3Health News: GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases – 4Health News:Moshi Names Independent Living Aids Exclusive Distributor in Blindness and Visual Impairment Field 2Health News:Moshi Names Independent Living Aids Exclusive Distributor in Blindness and Visual Impairment Field 3
(Date:11/24/2009)...swire-FirstCall/--AnadysPharmaceuticals,Inc.(Nasda...nnualPiperJaffrayHealthcareConferenceonTuesday,Dec...eisbeingheldatTheNewYorkPalaceHotel.SteveWorland,P...lprovideanoverviewofAnadysanditsclinicaldevelopmen...ntationwillbesimultaneouslywebcastandcanbeaccessed...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--ThoratecCorporation(Nas...rculatorysupporttherapiestosave,supportandrestoref...he21stAnnualPiperJaffrayHealthCareConferenceonTues...sidentandchieffinancialofficer,willprovideanupdate...me(5:30a.m.,PacificStandardTime). ,, Thepresent...
(Date:11/24/2009)...RNewswire/--PharmaceuticalInstitute,aleadingprovid...alandbiotechindustry,todayannouncedthelaunchofanew...alMarketplace e-courseisthenewestadditiontothecomp...ensiveseriesofe-coursesdesignedtofillthecriticalne...mercialprofessionals. ,, Thenewthreemodule Hosp...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 1Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 2Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 3Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 4Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 5Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 6Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 7Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 8Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 9Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 10Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results 48007 11Ratcliff Promotes Jorge Burbano to Senior Associate 3B Tess Kavanagh and Tony Keung to Associate 12477 1Ratcliff Promotes Jorge Burbano to Senior Associate 3B Tess Kavanagh and Tony Keung to Associate 12477 2Cambrex Regains Compliance With Revised NYSE Listing Standards 47999 1
...rs at Brigham and Women,s,Hospital found that pati...getting "high," but these effects were unrelated t...ir study, one of the first to examine the addictiv...resented today at the American,Academy of Pain Med...jay Wasan, MD MSc and colleagues found that when u...
...sts Leading Major Study into Lethal ,Super, Strain...ish Midlands Development Corporation today announc... are leading a major European study to unravel the... hospital acquired infections. , , The $4.5 milli...ology developed in Nottingham to study the functio...
Other Medicine Technology:Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 3
Stainless Steel Flexible Ruler
Sinuscope. A4.0AE70
Sinuscope. A4.0AE30
Sinuscope. A1.8AE30
Medicine Products: